Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age
PHASE1
The purpose of this study was to evaluate the safety, infectivity, and immu...
Status
Completed
Location
University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program
Evaluating the Infectivity, Safety, and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants and Children 6 to 24 Months of Age
PHASE1
The purpose of this study is to evaluate the safety, infectivity, and immun...
Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine, LID/ΔM2-2/1030s, in RSV-Seronegative Infants and Children 6 to 24 Months of Age
PHASE1
The purpose of this study is to evaluate the infectivity, safety, and immun...